|
|
|
Volumn 22, Issue 6, 2007, Pages 1-3
|
|
Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PROTEIN KINASE INHIBITOR;
ARTICLE;
DRUG EFFECT;
GENETICS;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METHODOLOGY;
MUTATION;
NUCLEOTIDE SEQUENCE;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SAFETY;
TREATMENT OUTCOME;
CARCINOMA, NON-SMALL-CELL LUNG;
DEVICE APPROVAL;
DNA MUTATIONAL ANALYSIS;
DNA, NEOPLASM;
HUMANS;
LUNG NEOPLASMS;
MUTATION;
PROTEIN KINASE INHIBITORS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
TREATMENT OUTCOME;
|
|
EID: 38449111242
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|